Nesher: Zydus arm gets USFDA nod for antibiotic to treat skin infection

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Nystatin Topical Powder USP, 100,000 units per gram.The drug will be produced at...